China SXT Pharmaceuticals (SXTC) has had the lowest return since January 1, 2026 by a US stock, returning -90.7%.
| ASSET | % RETURN |
|---|---|
China SXT Pharmaceuticals (SXTC) | -90.73% |
Mingteng International Corporation Inc Ordinary Shares (MTEN) | -84.74% |
Oriental Culture Holding (OCG) | -80.1% |
Sonder (SOND) | -75% |
Ping An Biomedical (PASW) | -62.26% |
Zenas BioPharma, Inc Common Stock (ZBIO) | -55.71% |
Signing Day Sports (SGN) | -47.1% |
CapsoVision, Inc Common Stock (CV) | -43.78% |
NUVB-WT (NUVB.WT) | -43.77% |
Bioatla (BCAB) | -41.9% |
XCF Global, Inc Class A Common Stock (SAFX) | -40.28% |
Aquestive Therapeutics (AQST) | -40.21% |
Diginex Limited Ordinary Shares (DGNX) | -38.52% |
X3 (XTKG) | -38.04% |
Everbright Digital Holding Limited Ordinary Shares (EDHL) | -37.5% |
Genelux Corporation Common Stock (GNLX) | -36.51% |
Instil Bio (TIL) | -36.11% |
CorMedix (CRMD) | -35.39% |
Beta Bionics, Inc Common Stock (BBNX) | -34.4% |
WeShop Holdings Limited Class A Ordinary Shares (WSHP) | -33.67% |
UTime (WTO) | -33.24% |
Hang Feng Technology Innovation (FOFO) | -33.19% |
LiveWire (LVWR) | -33.04% |
Claritev (CTEV) | -32.76% |
Dogwood Therapeutics (DWTX) | -32.14% |
